Molecular Quality Controls Market Size & Share, By Product (Independent Controls, Instrument Specific Controls), Analyte Type (Single-Analyte Controls, Multi-Analyte Controls), Application (Infectious Disease Diagnostics, Oncology Testing, Genetic Testing), End User (Diagnostic Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 3479| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Molecular Quality Controls Market size is set to increase from USD 212.94 million in 2024 to USD 399.72 million by 2034, with a projected CAGR exceeding 6.5% from 2025 to 2034. The industry revenue for 2025 is anticipated to hit USD 225.4 million.

Base Year Value (2024)
USD 212.94 million
CAGR (2025-2034)
6.5%
Forecast Year Value (2034)
USD 399.72 million
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Molecular Quality Controls Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: 1. Increasing demand for molecular diagnostics: One of the major growth drivers for the molecular quality controls market is the increasing demand for molecular diagnostics. Molecular diagnostics play a crucial role in the detection and monitoring of various diseases, including infectious diseases, cancer, genetic disorders, and more. The growing need for accurate and reliable molecular diagnostic tests is driving the demand for high-quality molecular quality controls, which are essential for ensuring the accuracy and reliability of test results. 2. Technological advancements in molecular testing: Technological advancements in the field of molecular testing have significantly contributed to the growth of the molecular quality controls market. The development of new and innovative molecular testing platforms and methods has led to increased adoption of molecular diagnostics in clinical settings. This, in turn, has created a greater need for high-quality molecular quality controls that can accurately mimic patient samples and provide reliable quality assurance for molecular tests. 3. Increasing prevalence of infectious diseases: The increasing prevalence of infectious diseases, such as HIV, hepatitis, and tuberculosis, is driving the demand for molecular quality controls. Molecular diagnostics play a critical role in the detection and monitoring of infectious diseases, and as the global burden of these diseases continues to rise, the demand for molecular quality controls is expected to grow substantially. 4. Growing focus on personalized medicine: The growing focus on personalized medicine is also driving growth in the molecular quality controls market. Molecular diagnostics are essential for identifying genetic variations and biomarkers that can inform personalized treatment decisions. As personalized medicine continues to gain traction in the healthcare industry, the demand for high-quality molecular quality controls to support these advanced molecular tests is expected to increase. Industry Restraints: 1. High cost of molecular quality controls: One of the major restraints in the molecular quality controls market is the high cost associated with these products. Quality controls are essential for ensuring the accuracy and reliability of molecular tests, but their high cost can pose a barrier to adoption, especially in resource-limited settings and developing countries. 2. Complex regulatory landscape: The molecular quality controls market is also restrained by the complex regulatory landscape governing these products. Stringent regulations and standards must be adhered to for the development, manufacturing, and distribution of molecular quality controls. Navigating these regulations can be challenging for manufacturers and may slow down the introduction of new products into the market. 3. Limited awareness and access in developing countries: Limited awareness and access to molecular quality controls in developing countries is another significant restraint for the market. In these regions, there may be a lack of knowledge about the importance of quality controls in molecular diagnostics, as well as limited access to high-quality products. Addressing these barriers and improving awareness and access in developing countries will be crucial for the growth of the molecular quality controls market.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Molecular Quality Controls Market
Largest Region
North America
XX% Market Share by 2034
North America: The molecular quality controls market in North America, particularly the United States and Canada, is expected to grow significantly due to the increasing adoption of molecular diagnostics and the presence of a well-established healthcare infrastructure. The presence of major market players and ongoing research and development activities in the region also contribute to the market growth. Asia Pacific: In Asia Pacific, countries such as China, Japan, and South Korea are witnessing a rapid growth in the molecular quality controls market. This can be attributed to the increasing investment in healthcare infrastructure, rising prevalence of chronic diseases, and growing awareness about the importance of early disease detection. Additionally, the expanding pharmaceutical and biotechnology sectors in the region are driving the demand for molecular quality controls. Europe: The molecular quality controls market in Europe, including the United Kingdom, Germany, and France, is projected to experience steady growth. The region benefits from the presence of advanced healthcare systems and a high level of healthcare expenditure. Furthermore, the increasing focus on personalized medicine and precision diagnostics in Europe is driving the demand for molecular quality controls in the region. Overall, the molecular quality controls market is expected to witness significant growth across North America, Asia Pacific, and Europe due to various factors such as increasing prevalence of chronic diseases, rising demand for quality assurance in molecular diagnostics, and technological advancements in the field of molecular testing.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Molecular Quality Controls Market Product: The product segment in the molecular quality controls market refers to the various types of molecular quality control products available in the market. This includes products such as nucleic acid-based controls, protein-based controls, and other types of controls that are essential for testing and monitoring the quality of molecular assays. These products play a critical role in maintaining the accuracy and reliability of molecular testing, and are widely used in clinical diagnostics, research laboratories, and pharmaceutical and biotechnology industries. Analyte Type: Analyte type refers to the specific target molecules or substances that are being measured or analyzed in molecular quality control testing. This segment includes a wide range of analytes such as nucleic acids, proteins, enzymes, and other biomolecules that are essential for various molecular assays. Analyte type plays a crucial role in determining the effectiveness and accuracy of quality control testing, and different types of analytes require specific quality control measures to ensure proper calibration and validation of molecular assays. Application: The application segment of the molecular quality controls market pertains to the various uses and purposes of quality control testing in molecular diagnostics and research. This includes applications such as infectious disease testing, oncology testing, genetic testing, and other specialized molecular assays. Quality control testing is essential in ensuring the accuracy and reliability of these molecular assays, and plays a critical role in enabling healthcare providers and researchers to make informed decisions based on the test results. End User: The end user segment of the molecular quality controls market encompasses the different types of healthcare facilities, laboratories, and research institutions that utilize quality control products for molecular testing. This includes hospitals, clinical laboratories, academic and research institutions, pharmaceutical and biotechnology companies, and other healthcare organizations. Each end user has specific requirements and preferences for molecular quality control products, and understanding these needs is crucial for manufacturers and suppliers to effectively cater to the diverse market demands.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The Molecular Quality Controls Market is highly competitive with a number of key players vying for market share. These companies offer a range of products and services including third-party quality control materials, analytical instruments, and software solutions for molecular testing. The market is characterized by intense competition, technological advancements, and ongoing research and development activities. Key players are focusing on strategic collaborations, partnerships, and mergers and acquisitions to expand their geographical presence and strengthen their product offerings. Other key strategies include product launches, innovations, and investments in R&D activities to gain a competitive edge in the market. Top Market Players: 1. Bio-Rad Laboratories, Inc. 2. Thermo Fisher Scientific Inc. 3. Roche Diagnostics 4. Abbott Laboratories 5. Siemens Healthineers 6. QIAGEN 7. BioMérieux 8. Randox Laboratories 9. Ortho Clinical Diagnostics 10. LGC Limited
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Molecular Quality Controls Market — Custom Segments

Segment Sub-Segment
No segment data available.

Molecular Quality Controls Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →